TriSalus Life Sciences In... (TLSI)

NASDAQ: TLSI · Real-Time Price · USD

5.06

-0.03 (-0.59%)

At close: May 02, 2025, 11:36 AM

TriSalus Life Sciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	n/a	-59.04M	-47.19M	-28.84M	-711.39K
Depreciation & Amortization	n/a	702K	398K	464K	321K
Stock-Based Compensation	n/a	1.4M	368K	109K	22K
Other Working Capital	-1.94M	953K	-2.57M	-1.84M	-569.98K
Other Non-Cash Items	-40.84M	6.15M	11.5M	6.54M	603.77K
Deferred Income Tax	n/a	n/a	310K	-832K	n/a
Change in Working Capital	n/a	740K	2.3M	-131K	-569.98K
Operating Cash Flow	-40.84M	-50.05M	-32.31M	-22.7M	-677.6K
Capital Expenditures	n/a	-1.12M	-786K	-1.26M	-545K
Cash Acquisitions	n/a	n/a	-1M	-1M	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	-250M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-345K	-1.53M	-1M	-1M	-9.16M
Investing Cash Flow	-345K	-2.12M	-1.79M	-2.26M	-250M
Debt Repayment	24.92M	-87K	-131K	-1.3M	-178.08K
Common Stock Repurchased	n/a	-20K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-2.52M	45.53M	94K	54K	n/a
Financial Cash Flow	37.94M	54.63M	13.46M	50.77M	252.01M
Net Cash Flow	-3.25M	2.46M	-20.64M	25.81M	-3.63M
Free Cash Flow	-41.19M	-51.17M	-33.1M	-23.95M	-1.22M